www.fdanews.com/articles/205746-euformatics-genomic-software-omnomicsngs-gets-ce-ivd-mark
Euformatics’ Genomic Software omnomicsNGS Gets CE-IVD Mark
December 13, 2021
Euformatics’s genomic variant interpretation and reporting software tool, omnomicsNGS, has been granted a CE-IVD mark.
The software, which is available as a cloud-based installation or for installing locally on the customer’s hardware, is primarily designed for clinical use.
OmnomicsNGS provides flexibility and security to clinical users of next-generation sequencing (NGS) data, whatever their set-up, the Helsinki, Finland-based company said.